Chiome Bioscience Inc. (4583.T)
JPY 272.0
(-3.2%)
JPY 272.0
(-3.2%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 398.59 Million JPY | 14.26% |
| 2022 | 348.85 Million JPY | -17.42% |
| 2021 | 422.45 Million JPY | 72.24% |
| 2020 | 245.27 Million JPY | -13.83% |
| 2019 | 284.64 Million JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 77.75 Million JPY | 36.42% |
| 2024 Q1 | 56.99 Million JPY | -37.71% |
| 2023 Q3 | 98.41 Million JPY | -12.71% |
| 2023 Q2 | 112.73 Million JPY | 17.51% |
| 2023 Q1 | 95.94 Million JPY | -15.74% |
| 2023 FY | 398.59 Million JPY | 14.26% |
| 2023 Q4 | 91.5 Million JPY | -7.02% |
| 2022 Q3 | 83.86 Million JPY | 0.0% |
| 2022 FY | 348.85 Million JPY | -17.42% |
| 2022 Q4 | 113.86 Million JPY | 35.78% |
| 2021 FY | 422.45 Million JPY | 72.24% |
| 2020 FY | 245.27 Million JPY | -13.83% |
| 2019 FY | 284.64 Million JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | 78.813% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | -396.345% |
| GNI Group Ltd. | 22.43 Billion JPY | 98.223% |
| Linical Co., Ltd. | 3.77 Billion JPY | 89.45% |
| Trans Genic Inc. | 2.24 Billion JPY | 82.279% |
| MEDINET Co., Ltd. | 98.25 Million JPY | -305.686% |
| Soiken Holdings Inc. | 2.48 Billion JPY | 83.943% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | 69.164% |
| AnGes, Inc. | -3.06 Billion JPY | 113.004% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 324.285% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 95.875% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | 22.946% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | -259.237% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | 72.522% |
| CanBas Co., Ltd. | -984 Million JPY | 140.508% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | -1.761% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | 75.932% |
| Kidswell Bio Corporation | 1.03 Billion JPY | 61.651% |
| PeptiDream Inc. | 17.21 Billion JPY | 97.685% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | -1202.385% |
| Ribomic Inc. | -10.5 Million JPY | 3895.42% |
| SanBio Company Limited | -14.5 Million JPY | 2848.173% |
| Healios K.K. | 108 Million JPY | -269.069% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | 116990.029% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | 775.058% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | 26462.103% |
| StemRIM | -44.34 Million JPY | 998.769% |
| CellSource Co., Ltd. | 3.18 Billion JPY | 87.485% |
| FunPep Company Limited | -680.28 Million JPY | 158.592% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -475.588% |
| Stella Pharma Corporation | 217.29 Million JPY | -83.432% |
| TMS Co., Ltd. | -6.95 Million JPY | 5835.18% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | -26.715% |
| Cuorips Inc. | 9.63 Million JPY | -4038.667% |
| K Pharma,Inc. | 910 Million JPY | 56.198% |
| Takara Bio Inc. | 25.45 Billion JPY | 98.434% |
| ReproCELL Incorporated | 1.1 Billion JPY | 63.919% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | 66.646% |
| StemCell Institute Inc. | 1.57 Billion JPY | 74.707% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | 76.086% |
| CellSeed Inc. | 107.15 Million JPY | -271.98% |